在临床前瘤生长抑制研究中的实验设计考虑和统计分析
Vinicius Bonato1, Szu-Yu Tang1, Matilda Hsieh2
1Nonclinical Statistics, Pfizer Inc, La Jolla, California, USA.
Pharmaceutical statistics
|June 10, 2024
概括
本教程指导研究人员设计和分析用于癌症药物开发的动物研究. 它涵盖了瘤生长抑制 (TGI) 研究方法,统计分析和有效的临床前研究的R脚本.
科学领域:
- 临床前瘤学研究研究
- 动物研究设计
- 药物开发中的生物统计学
背景情况:
- 动物模型对于癌症药物发现至关重要,有助于标识和候选药物选择.
- 瘤生长抑制 (TGI) 研究对于在临床试验之前优先考虑抗癌化合物至关重要.
研究的目的:
- 为动物癌症研究提供研究设计和数据分析的全面概述.
- 专注于TGI研究,涵盖实验设计,统计分析和R脚本编写.
主要方法:
- 讨论实验设计:模型选择,终点选择 (瘤体积,生长率,事件,分类),错误/偏差考虑,样本大小和缺失的数据.
- 统计分析的审查:连续终点 (单一/纵向),时间到事件分析,分类终点和药物组合协同作用.
- 包括R样本脚本用于实际数据分析.
主要成果:
- 该教程概述了强大的TGI研究设计和分析的方法.
- 它详细介绍了各种终点类型和复杂场景 (如药物组合) 的统计方法.
- 提供了实用的R脚本以促进数据分析.
结论:
- 有效的研究设计和适当的统计分析对于可靠的临床前癌症研究至关重要.
- 本教程为研究人员提供了进行和分析TGI研究的知识和工具.
- 使用R脚本可以提高抗癌药物开发中的数据解释效率和准确性.
更多相关视频
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
10.2K
11:09Establishing Intracranial Brain Tumor Xenografts With Subsequent Analysis of Tumor Growth and Response to Therapy using Bioluminescence Imaging
Published on: July 13, 2010
39.3K
相关概念视频
Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
Cancer Survival Analysis
343
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
343
